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Facial expression is an important part of human communication. Loss of facial symmetry and
mimetic function after facial nerve injury has an enormous impact on the psychosocial
conditions of the patients. Therefore, surgical restoration of the facial nerve and muscles is a
great challenge. Patients with severe long-term facial paralysis are often reanimated with a
two-stage procedure combining cross-facial nerve grafting, and 6 to 8 months later with
microneurovascular (MNV) muscle transfer. Many factors contribute to the functional
outcome of reconstruction; some of them are well-known but there are still many questions
unanswered.
Material and Methods
In this thesis, we recorded the long-term results of MNV surgery in facial paralysis and
observed the possible contributing factors to final functional and aesthetic outcome after the
two-stage MNV reanimation procedure. Twenty-seven out of forty patients operated on were
interviewed, and the functional outcome was graded on House’s scale. Hospital charts were
reviewed to collect demographic and clinical data. Fifteen patients were available for the
magnetic resonance imaging of MNV muscle flap to describe the survival and volume of
these flaps. Nerve graft samples (n=37) were obtained in the second stage of the operation.
Muscle biopsy samples (n=18) were taken from MNV muscle flaps during secondary
refinement procedures. The structure of MNV muscles and nerve grafts was evaluated using
basic histology and immunohistochemical methods. Immunohistochemistry for muscle
biopsies revealed muscle fiber type distribution (anti-myosin fast), proliferating satellite cells
(Ki-67) and reinnervation indicating the Schwann cells (S-100). Muscle atrophy was assessed
histomorphometrically. Immunohistochemistry for nerve graft samples revealed number of
viable axons (NF-200), Schwann cells (S-100) and vascular structures (CD-31) within the
nerve graft. Immunoreactivity for p75 nerve growth factor receptor (p75NGFR), vascular
endothelial growth factor (VEGF) and vascular endothelial growth factor receptors (Flt-1,
Flk-1) was also characterized in nerve graft samples. Statistical analysis was performed,
comparing the data obtained.
Results
1. Two-thirds of the patients achieved good result in facial reanimation defined as mild or
moderate dysfunction. The longer the follow-up time after muscle transfer the weaker was the
muscle function. A majority of the patients (78%) defined their quality of life improved after
surgery.
2. In magnetic resonance images (MRI), the volume of the free MNV flaps declined
significantly with the follow-up. A correlation was found between good functional outcome
and normal muscle structure in MRI.
3. In muscle biopsies, the mean muscle fiber diameter was diminished to 40% compared to
control values. Muscle atrophy was not type specific. Proliferative activity of satellite cells
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was seen in 60% of the samples and it tended to decline with an increase of follow-up time.
All samples showed intramuscular innervation. Severe muscle atrophy correlated with
prolonged intraoperative ischaemia. The good long-term functional outcome correlated with
dominance of fast fibers in muscle grafts.
4. In nerve grafts, the mean number of viable axons (NF-200) amounted to 38% of that in
control samples. The grafted nerves were characterized by fibrosis and invasion of
inflammatory cells, and regenerated axons were thinner than in control samples. A longer
time between cross facial nerve grafting and biopsy sampling correlated with a higher number
of viable axons. P75NGFR was expressed in every nerve graft sample. The expression of
p75NGFR was lower in older than in younger patients. A high expression of p75NGFR was
often seen with better function of the transplanted muscle.
5. Density of vascular structures corresponded to that of control nerves. In grafted nerve
VEGF, Flt-1 and Flk-1 were expressed in nervous tissue. In control samples, the VEGF
expression was low and located mainly in myelin sheaths.
Conclusions
In conclusion, most of the patients achieved good result in facial reanimation and were
satisfied with the functional outcome. The mimic function was poorer in patients with longer
follow-up time. MRI can be used to evaluate the structure of the microneurovascular muscle
flaps. Regeneration of the muscle flaps was still going on many years after the transplantation
and reinnervation was seen in all muscle samples. Grafted nerves were characterized by
fibrosis and fewer, thinner axons compared to control nerves. All nerve grafts were well
vascularized. P75NGFR and VEGF were expressed in human nerve grafts with higher
intensity than in control nerves which is described for the first time.
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INTRODUCTION
Free muscle flaps provide an important source of tissue when reconstructing tissue defects or
functional deficits due to congenital problems or acquired diseases. In free muscle transfers,
the muscle is harvested with its arterial and venous vessels and transferred to the site of the
deficit. The vessels of the flap are connected microsurgically to the recipient vessels, and the
muscle is settled to fill in the defect. In functional free muscle transfer, muscle is harvested
with its blood vessels but also with its nerve. Both the vessels and the nerve are connected to
the chosen recipients, muscle is reattached to the surroundings to gain the function, and after
satisfactory neural and muscular regeneration, the microneurovascular muscle flap begins to
function. (Mathes et Hansen, 2006)
In severe facial paralysis treated with functional free muscle transfer, optimal conditions for
nerve regeneration via the cross-over nerve graft and the best possible muscle regeneration are
crucial to regain  mimetic function after paralysis. The functional goals for facial reanimation
are to return facial symmetry at rest with oral competence and creation of  involuntary smile.
Good aesthetic results can be gained with sufficiently small free muscle and with optimal
placement of scars. Despite enormous research in the field of surgical technique regarding
nerve repair and microneuromuscular flap requirements, there are still a lot of questions to be
answered in order to obtain an optimal functional and aesthetic result for the patient.
The present study was designed to elucidate some of the factors affecting the final functional
outcome of  facial reanimation by two-stage microneurovascular muscle transfer and to
characterize the morphology of the nerve grafts and free microneurovascular muscle flaps by
radiological and immunohistochemical methods. Better knowledge of  clinical and biological
parameters functioning in facial reanimation would benefit the patients with facial paralysis.
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REVIEW OF THE LITERATURE
1. Facial paralysis
1.1 Anatomy
Loss of function of the facial nerve leads to facial paralysis which means paralysis of the
muscles innervated by the facial nerve, the seventh cranial nerve. The course of the facial
nerve is presented in Figure 1 (modified from Gray’s Anatomy, 1977). The facial nerve is the
motor nerve of all the muscles of expression in the face, and of platysma and buccinator; the
muscles of the external ear; the posterior belly of the digastric, and the stylohyoid. It has the
four distinct components including the voluntary motor fibers but also parasympathetic fibers
to the lacrimal, submandibular and sublingual glands; sensory innervation to the part of the
external ear and its chorda tympani branch contributions to taste at the anterior two-thirds of
the tongue. Its tympanic branch supplies the stapedius (Myckatyn et Mackinnon, 2004).
Figure 1. Course of the facial nerve.
For the surgical reconstruction it is necessary to know the course of the extratemporal facial
nerve. It leaves the facial canal of the temporal bone coming through the foramen
stylomastoideum. It runs in the deep layers below the earlobe, where muscular branches are
given off to the occipital, auricular, posterior digastric and stylohyoid muscles. The nerve
becomes more superficial before it enters the parotid gland dividing the gland into superficial
and deeper parts. Inside the gland, the facial nerve trunk usually divides into superior and
inferior divisions, temporo-facial and cervico-facial branches. The facial nerve, running more
superficially and distally after the parotid part, divides further into 8-15 branches.
Traditionally, five main portions are called frontal (or temporal), zygomatic, buccal, marginal
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mandibular and cervical branches but their exact anatomic locations are somewhat variable
(Myckatyn et Mackinnon, 2004). (Figure 2, modified from Myckatyn et Mackinnon, 2004).
Figure 2. Main branches of the facial nerve.
Facial musculature comprises 17 paired muscles, and one unpaired sphincter-like muscle, the
orbicularis oris. Coordination between these muscles is essential for subtle facial expression.
The major muscles affecting the forehead and eyelids are the frontalis, corrugator and
orbicularis oculi. There are two groups of muscles controlling the movement of the lips. The
lip retractors include the levator labii superioris, levator anguli oris, zygomaticus major and
minor for upper lip, and depressor labii inferioris and depressor anguli oris for the lower lip.
The antagonists to these lip-retracting muscles is the orbicularis oris, which is responsible for
oral continence and some expressive movements of the lips. The mimetic muscles are
arranged in four layers so that buccinator, mentalis and levator anguli oris make up the
deepest layer. Except for these three muscles, all the other facial muscles receive innervation
from facial nerve branches entering deep surfaces. (Zuker et al, 2006)
1.2 Classification and Etiology
It is estimated that idiopathic facial paralysis affects 13-30 people per 100 000 person years
worldwide (Rowlands et al, 2002; Kanerva et Pitkäranta, 2006). Peripheral facial nerve
paralysis may cause paralysis of all the above-mentioned mimetic muscles. For the patient,
this means brow ptosis, inability to close the eyes, and lower lid drooping causing corneal
exposure, desiccation and tears running down the cheek. There is smoothness of the cheek,
nasolabial furrow becomes loose and the nostrils can not be dilated. The mouth is drawn to
the affected side, causing asymmetry of the face and inability to smile, whistle or grin. Food
is collected between cheek and gum, causing problems with oral continence.
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Facial paralysis can affect both young and old, and may be congenital or acquired. Paralysis
can be unilateral or bilateral, and degree of muscle involvement varies from partial to total
paralysis.
The duration of the paralysis also varies: most patients regain the function of the muscles
spontaneously and approximately 3-4 percent of all the patients with idiopathic paralysis will
have long-term facial paralysis (Kanerva et Pitkäranta, 2006).
Most common aetiologies of facial paralysis are shown in Table 1 (modified from Zuker et al,
2006).
1.3. Assessment of mimetic function
Numerous grading systems have been developed to quantify the extent of facial paralysis and
the final functional outcome of the patient after the surgical treatment (House, 1983; O´Brien
et al, 1990; Murty et al, 1994; Sargent et al, 1998; Frey et al, 1999; Chee et Nedzelski, 2000;
Brenner et Neely, 2004). One of the well-established standard methods is House’s grading
system (House, 1983). The degree of dysfunction is clearly defined on a scale from one to six
as presented in Table 2. The evaluation is based on each patient´s interview, and it is therefore
subjective. Computer-assisted methods for assessing mimic function are also developed, but
they are more expensive and time consuming as there is a need for special hardware and
software when using them (Murty et al, 1994; Sargent et al; 1998; Frey et al, 1999).
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Table 2. House scale (House, 1983)
Grade Definition
I. Normal Normal facial function in all areas.
II. Mild dysfunction Slight weakness noticeable only on close inspection. At rest:
Normal symmetry and tone. Motion: some to normal movement of
forehead; ability to close eye with minimal effort and slight
asymmetry; ability to move corners of mouth with minimal effort
and slight asymmetry. No synkinesis, contracture or hemifacial
spasm.
III. Moderate dysfunction Obvious but not disfiguring difference between two sides; no
functional impairment; noticeable but not severe synkinesis,
contracture or hemifacial spasm. At rest: normal symmetry and
tone. Motion: slight to no movement of forehead; ability to close
eye with maximal effort and obvious asymmetry; ability to move
corners of mouth with maximal effort and obvious asymmetry.
Patients with obvious but not disfiguring synkinesis, contracture or
hemifacial spasm are Grade III regardless of degree of motor
activity.
IV. Moderately severe dysfunction Obvious weakness or disfiguring asymmetry. At rest: normal
symmetry and tone. Motion: no movement of forehead; inability to
close eye completely with maximal effort; asymmetrical movement
of corners of mouth with maximal effort. Patients with synkinesis,
mass action or hemifacial spasm severe enough to interfere with
function are Grade IV regardless of degree of motor activity.
V. Severe dysfunction Only barely perceptible motion. At rest: possible asymmetry with
droop of corner of mouth and decreased nasal labial fold. Motion:
no movement of forehead; incomplete closure of eye and only slight
movement of lid with maximal effort; slight movement of corner of
mouth. Synkinesis, contracture or hemifacial spasm usually absent.
VI. Total paralysis Loss of tone; asymmetry; no motion; no synkinesis, contracture or
hemifacial spasm.
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2. Conservative treatment of facial paralysis
The clinical picture of facial paralysis may vary a lot between the patients. Approximately 96
percent of all the patients with facial palsy will regain spontaneously the function of the facial
nerve (Kanerva et Pitkäranta, 2006).
In randomized controlled studies it has been shown that there is no significant benefit from
treating idiopathic paralysis (Bell’s palsy) with corticosteroids (Salinas, 2008).
Non-surgical approaches may apply temporary protection to the eye. Lid-taping (particularly
when sleeping), eye lubrication using clear watery drops, soft contact lenses, and modification
of eye-glasses are examples of this treatment. Physiotherapy and speech therapy to establish
control of specific muscles or muscle groups are important elements in both pre- and
postoperative treatment protocols (Byrne et al, 2004). This consists of various treatment
modalities such as biofeedback and self-directed mirror exercises using slow, small and
symmetric movements (Zuker et al, 2006).
3. Surgical treatment of facial paralysis
There are several ways of reanimating the face after facial paralysis depending on the
aetiology, the duration of the palsy, and the patients’ age and life expectancy. Also, the
opinion of the patient is important as there are many different options for treating facial
paralysis, within certain limits. Timing of the surgery related to the duration of paralysis,
condition of the nerve stump and possible tumour involvement within the facial nerve
determines the method of surgical treatment. In general, the aims of treatment are to protect
the eye, to provide symmetry at rest, and to provide movement. The goals of treatment for the
eye are to maintain vision, to provide protection, to maintain function of the eyelids, to
improve cosmesis, and to enable the eye to express emotion. The goals for the mouth are to
correct asymmetry, to provide oral continence, to improve speech and to provide a balanced
symmetric smile (Zuker et al, 2006).
Surgical methods can be divided into static and dynamic procedures. Static procedures
include supportive slings (fascia lata or alloplastic sheets), brow or forehead lifts, facelifts,
lower lip wedge resections and use of botulinum toxin (Shindo, 1999). Dynamic procedures
are presented more detailed in this review.
3.1 Direct nerve repair
Lacerations and iatrogenic injuries of the facial nerve are best repaired immediately in order
to achieve the ideal results. The basic principles in peripheral nerve repair apply also to the
facial nerve. Microsurgical technique and instrumentation, adequate preparation of nerve
ends, avoidance of tension at the suture line and use of smallest calibre sutures that will
secure interfascicular and epineurial repair (Millesi, 1972).
It is within the first 30 days after the injury that the neural and muscular elements have the
best chance of complete recovery (Conley et May,  2003). In addition, the anatomy is not
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hampered by fibrosis and scarring. When repair is delayed beyond that time, the results
diminish in strength and quality but are still acceptable until a year (Conley et May, 2003).
3.2 Nerve grafting
The most commonly used donors for nerve grafts are the great auricular, sural, lateral
cutaneous femoral nerves or branches of the cervical plexus from the ipsilateral side of the
neck (May, 2003a; Lee et al, 2008). Great auricular and sural nerves are ideal to repair the
facial nerve in terms of their availability, axon content and length (May, 2003a). In cases
where there is a loss of the main trunk or peripheral parts of the facial nerve secondary to
trauma, scarring and tumour resection, primary nerve grafting may be the treatment of choice
(Tate et Tollefson, 2006). Grafting requires survival of motor end plates in the target muscles
which are not present after approximately two years due to motor end plate fibrosis and
atrophy (Tate et Tollefson, 2006). The expected rate of axonal regeneration is approximately
1 mm/day, and adequate facial tone can be achieved after 6 months and restoration of motion
1-3 months later (Shindo et al, 1999).
3.3 Cranial nerve substitution techniques
Several procedures have been advocated for late restoration of facial function. When the
proximal stump of the facial nerve is not available, the cranial nerve substitution is
considered, particularly when repair can be achieved within one to two years after injury
(Conley et May, 2003). Although involuntary mimetic movement is not possible with these
procedures except when using the contralateral facial nerve (VII cranial nerve), they provide
good voluntary facial movement and symmetry at rest. Facial movements develop within 4 to
6 months of the nerve substitution, improving for up to several years (May, 2003b).
These procedures include spinal accessory nerve cross-over (Drobnick, 1902), cross-facial
nerve grafting, (Smith, 1971; Scaramella et Tobias, 1973; Anderl, 1973), ipsilateral
hypoglossal nerve cross-over (Conley et Baker, 1979), ipsilateral hypoglossal nerve cross-
over with a jump graft (May, 2003b) and a babysitter principle using ipsilateral hypoglossal
nerve in conjunction with cross facial nerve graft (Terzis, 1990; Kalantarian et al, 1999). The
major disadvantage of donor nerve techniques is that a functional cranial nerve must be
sacrificed.
The spinal accessory nerve (XI cranial nerve) is not considered as a first choice for the donor
nerves for facial reanimation. Complete sectioning of the nerve can produce significant
shoulder weakness, and also unpleasant mass contractions of the facial muscles are possible.
(Klebuc et Shenaq, 2004).
The use of the entire hypoglossal nerve (XII cranial nerve) frequently leads to a paralysed,
atrophied hemitongue with consequences like impaired talking, chewing, and swallowing.
Moreover, hypoglossal–facial transfer can be associated with mass movements of the
reinnervated face, setting new demands on central nervous system plasticity (Bernat et al,
2006). The functional deficit produced by complete XII-VII transfer can be reduced by
utilizing a jump graft technique. An interposition nerve graft is sutured in an end-to-side
fashion to nerve XII, followed by an end-to-end repair to nerve VII (Klebuc et Shenaq, 2004).
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Cross-facial nerve grafting procedure was described by several surgeons (Smith, 1971;
Scaramella et Tobias, 1973; Anderl, 1973). A nerve graft is placed as a conduit between the
branches of the healthy, contralateral side of the facial nerve and corresponding facial nerve
branches on the paralysed side as presented in Figure 3 (modified from Zuker et Eppley,
2000). The goal is to provide coordinated spontaneous mimetic function. The disadvantage of
this procedure is that it sacrifices normal facial function on the healthy side for the potential
benefit of the paralysed side. The more distal the branches used on the normal side, the less
efficacy is provided; the more proximal, the greater is the donor effect.  The regenerating
axons must cross two suture lines and traverse a nerve graft of up to 24 cm in length. A
significant size mismatch between the facial nerve branches and nerve graft usually exists.
(Klebuc et Shenaq, 2004). Cross-facial nerve grafting also requires a long time, usually 8 to
12 months, for nerve regeneration to reach cross the face to contralateral denervated facial
muscles in critical need of trophic support (Tate et Tollefson, 2006).
Figure 3. Cross-facial nerve graft
Cross-facial nerve grafting is particularly best suited for cases of incomplete facial paralysis
of less than 6 months duration. It can also be used for individuals with complete hemifacial
paralysis of less then 1 year duration. In these cases the cross-facial nerve graft is utilized to
reinnervate the orbicularis oculi muscle and for example masseteric nerve is used to reanimate
the corner of the mouth. In addition, it can be used for severe cases in combination with
microneurovascular muscle transplants. (Klebuc et Shenaq, 2004).
Terzis introduced the “babysitter” procedure, which is a combination of cross-facial nerve
grafting and partial hypoglossal nerve transfer with an end-to-side coaptation with the
ipsilateral facial nerve (Terzis, 1990). The superiority of this procedure is in providing
symmetrical and coordinated facial motion using cross-facial nerve grafting while taking
advantage of rapid reinnervation from the ipsilateral hypoglossal nerve to maintain the bulk of
the facial muscles without leaving the tongue denervated (Kalantarian  et al, 1999).
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3.4 Muscle transposition techniques
Regional muscle transfer may be a good solution for patients who are not candidates for
extensive surgery (May, 2003c). These techniques involve the transplantation of the
temporalis muscle (Gillies 1934; Mc Laughlin 1953; Labbe et Huault, 2000), the masseter
muscle or both (Rubin, 1977; Conley et Baker,1979). The traditional Gillies’ technique
comprised a retrograde transfer of the temporalis muscle, so that the origin of the muscle is
detached from the fossa temporalis and turned over the zygomatic arch to extend to the oral
commisure. The major disadvantage of this technique is the need for a fascial graft and the
placement of the temporalis muscle over the zygomatic arch causing bulging (Labbe et
Huault, 2000). In addition, to activate a smile, the patient must clench the teeth. Mc Laughlin
suggested an antegrade transfer of the temporalis muscle. This technique was further
developed by Labbe, who stopped using a fascial graft and instead transferred the temporalis
tendon together with a bony part of the coronoid process under the zygomatic arch, tunneled it
through the subcutis of the cheek and attached it to the lip commisure (Labbe et Huault,
2000).
The masseter plastia involves transplanting the whole, or the anterior part of the muscle from
its insertions on the mandible and re-inserting it around the mouth (Baker et Conley,1979).
Good static control of the mouth can be achieved but the major disadvantages with the
masseter plastia are that it creates too horizontal and weak action on the lip and commisure
and leaves the angle of the mandibulae looking hollow.
Clinical observations suggest that at least partial spontaneous facial muscle reinnervation
takes place from the trigeminal pathway after regional muscle plasties (Labbe et Huault,
2000).
3.5 Protection of the eye
Lagophthalmos and dysfunctional tearing are not only troublesome but can lead to painful
corneal exposure and ulcerations. The use of upper eyelid gold weights is a standard of care to
be combined with other methods of reanimating the face (Tate et Tollefson, 2006). Paralytic
ectropion can be corrected by performing wedge excision of the lateral lower eyelid and
lateral canthopexy, sometimes even medial canthopexy is required (Shindo, 1999). The eye
can be protected also by contralateral  frontal muscle transposition or even with
microneurovascular muscle transfer using a part of the muscle or a thin separate muscle as
platysma (Terzis, 2004).
3.6  Microneurovascular free muscle transfer
Functioning free muscle transfer is today becoming more and more accepted as the first
choice of reconstruction for long-lasting total facial paralysis to restore emotional expression
of the face and possibly subconscious smile (Harii et al, 1976; Harrison ,1985 ; O’Brien et al,
1990; Terzis et Noah, 1997; Frey et Giovanoli, 2002; Chuang, 2002). Free muscle transfer is
indicated when native facial muscles cannot be reinnervated due to the paralysis longer than
two years causing severe atrophy of the mimetic muscles. Younger patients who desire
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mimetic dynamic reconstruction and are willing to accept long waiting for the results are
optimal candidates for this technique (Swartz, 2003).
The two-stage method to reanimate long-standing facial paralysis by cross-facial nerve
grafting and later free microneurovascular muscle transfer has been the standard treatment of
choice for almost 30 years (Harii, 1979). Schematic drawing of the procedure proposed by
Harii (Harii, 1979) is presented in Figure 4A, and the other possibility to place the grafts is
presented in Figure 4B (O’Brien et al, 1980).
Figure 4A and B. Schematic drawings of the possibilities to place the nerve grafts and free
muscle transplant in facial reanimation.
Figure 4A. Figure 4B
In the first stage the aim is to use the healthy side of the face as a motor donor and by cross-
facial nerve grafting bring the innervation to the paralyzed side from the healthy facial nerve.
The only technique currently available to restore both voluntary and involuntary facial
movements plus symmetry at rest requires the use of the facial nerve (VII cranial nerve)
(Zuker et al, 2006). Preoperative analysis of the type of smiling the patient has on the
nonparalysed side is crucial for a symmetrical result. Individuals have various types of smiles,
and it is important to assess the direction of movement of the upper lip and commisure (Paletz
et al,1993).
The nerve graft, which is usually a sural nerve, is harvested and tunnelled across the upper lip
or under the chin to connect the healthy side to the preauricular area on the paralyzed side. It
may be coapted to contralateral facial nerve either end-to-end or end-to-side (Terzis et Noah,
2002; Frey et al, 2006).
Many free muscle flaps have been used for facial reanimation: gracilis (Harii, 1976; Terzis et
Noah, 1997; Frey et Giovanoli 2002), pectoralis minor (Harrison, 1985; Terzis, 1989),
latissimus dorsi (Harii, 1979), serratus anterior (Whitney et al, 1990), rectus femoris
(Koshima et al, 1994), rectus abdominis (Hata et al, 1990), extensor digitorum brevis of the
foot (Mayou et al, 1981), abductor hallucis (Jiang et al, 1995) and external oblique muscle
(Kuzbari et al, 1997). The most commonly transferred muscles are the gracilis, latissimus
dorsi and pectoralis minor, the latter is used with good results especially in paediatric patients
(Terzis et Noah,1997; Harrison, 2005).
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In the second stage, that usually is performed 8-12 months after the first operation, when a
positive Tinell sign can be recalled at the distal end of the cross-facial nerve graft, a
microneurovascular muscle transplantation is performed. The carefully tailored muscle graft
is brought to the cheek area with the vascular and neural pedicles superficially. It is fastened
with its distal parts fan-shaped divided into the upper and lower lips, sometimes with a small
part placed into the alar base. The proximal part can be pulled gently to ascertain a smile. The
upper fibers are brought as close to the zygomaticus as possible  and inserted into the malar
area (Harrison, 2002). The muscle is then spread out along the zygomatic arch into the SMAS
in the preauricular region and down to the sternomastoid fascia to the lowest part. (Harrison,
2002). Vascular anastomoses are performed to the facial or the superficial temporal vessels,
depending on which muscle is used and how it is placed. Nerve anastomosis is performed to
the clean cut distal end of the cross-facial nerve graft (Chuang, 2002).
Above is described one possibility of performing a two-stage procedure in facial reanimation.
The technical details may vary according to the patient and the surgeon.
The patient is monitored for circulation problems in the flap, postoperative haematoma or
infection. When the postoperative period is uneventful, function appears in the muscle graft 6-
12 months after transfer providing satisfactory elevation of the nasolabial fold corresponding
well with contralateral facial movements (Harii et al, 1979).
Some authors recommend electric stimulation of the  muscle graft until the muscle begins to
contract. The active muscle training should be started when the muscle can be controlled by
the patient, often with the help of  physiotherapist. Active muscle training should be
continued to gain not only muscle contraction but also coordinated facial movements. (Frey et
Giovanoli, 2002)
Results after the two-stage reanimation are usually from moderate to good varying in different
patient series as many factors contribute to the functional outcome (O´Brien et al, 1990;
Sassoon et al, 1991; Terzis et Noah, 1997; Kumar et Hassan, 2002). Restoration of the
original resting tension of the muscle graft (Terzis et al, 1978; Frey et al, 1983) and
meticulous coaptation of the nerve (Manktelow et al, 1984) between the donor nerve and the
motor nerve of the muscle graft have proved to be of great importance. Failures can be
attributed to vascular thrombosis, lack of innervation or both. Morover, optimal results
depend on muscle inset to the face, bulkiness and strength of the muscle (Swartz, 2003).
Possible late problems with microneurovascular muscle transfer include persistent bulkiness
of the muscle transplant and synkinesis or mass movements in the face. Donor-side sequelae
after harvesting the sural nerve may result in numbness of the lateral area of the foot, pain or
scar hypertrophy (Zuker et al, 2006). Synkinesis is defined as the abnormal, simultaneous
contraction of a group of muscles with voluntary or involuntary facial expression. This
phenomenon occurs when regenerating axons innervate unintended targets (Rovak et al,
2004a).
Nowadays, microneurovascular reanimation of the face can be carried out also in one stage
(Chuang, 2002). In the one-stage procedure, microneurovascular muscle with a longer neural
pedicle such as latissimus dorsi or rectus abdominis is connected to the healthy side of the
facial nerve directly without the cross-over nerve graft (Harii et al, 1998; Kumar et Hassan,
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2002). The advantages are that the patient undergoes only one operation , no nerve graft is
needed, and mimetic function reappears sooner (Takushima et al, 2002). The disadvantages of
the one-stage procedure are the limited freedom of positioning the muscle graft and possible
problematic scar development (Guelinckx et Sinsel, 1996; Rab et al, 2006).
When there is neither an ipsilateral nor a contralateral facial nerve available to act as a donor,
as for example in the classical Moebius patient, other motor donors must be used to innervate
the microneurovascular muscle flap. Objective testing of bilateral cranial nerve motor
function and electrophysiological tests are crucial in order to avoid causing further
impairment to the patient by reconstructive surgery. The facial nerve excluded, possible motor
donors are the trigeminal (V), the spinal accessory (XI), and the hypoglossal (XII) nerves.
The hypoglossal nerve is often affected in Moebius patients, and should therefore be left
intact (Terzis et Noah, 2002). The masseter branch of the trigeminal nerve is often used while
gracilis transfer to this nerve can be performed in one stage (Zuker et al, 2000; Terzis et Noah,
2002) In the majority of children and in 50 % of adult patients, due to possible reorganization
of the cerebral cortex, this procedure can provide a symmetric smile with exellent muscle
excursion without conscious effort or biting motion (Zuker et al, 2000). In rare cases of
Moebius syndrome the cervical or brachial plexus can be used as motor sources (Terzis et
Noah, 2002).
In most cases, after microneurovascular reconstruction, a tertiary refinement procedure will be
needed later. Depending on the patient and the functional result, these procedures include
brow-lifts, face-lifts, blepharoplasties, repositioning of the grafted muscle, static slings or
functional coupling by botulinum toxin (Zuker et Eppley, 2000; Tate et Tollefson, 2006).
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4. Structure of free muscle flaps in magnetic resonance imaging
Magnetic resonance imaging (MRI) is an accurate imaging method for evaluating muscles
(Murphy et al, 1986; Lamminen et al, 1990; Fleckenstein et al, 1993). Clinical MRI studies oo
normal skeletal muscles have obtained clear delineation between muscle tissue, intermuscular
fat, subcutaneous fat and cortical bone in T1-weighted, proton density-weighted and T2-
weighted images (Murphy et al, 1986; Fisher et al, 1986) . Subcutaneous fat has been shown
to be a useful and stable reference tissue for signal intensity evaluations in MRI (Dooms et al,
1986). MRI studies in patients with different neuromuscular diseases show different patterns
of changes in the size and signal intensity of muscles (Murphy et al, 1986; Lamminen et al,
1990; Hudgins et al, 1994).
Many studies have been conducted on the MRI appearance of denervated skeletal muscles
including both traumatic and postoperative neuropathies and denervated free microvascular
muscle flaps  (Murphy et al, 1986; Lamminen et al, 1990; Fleckenstein et al, 1993; Salmi et
al, 1995; Chong et al, 2001; Fischbein et al, 2001; Bendszus et al, 2002).
The changes that accompany motor denervation include asymmetrical decrease in affected
muscle volume, fatty infiltration and variable signal intensity changes as T1 and T2
prolongation and postcontrast enhancement (Fleckenstein et al, 1993; Uetani et al, 1993;
Russo et al, 1997).
In clinical denervation studies paralyzed muscles showed high signal intensity on T2-
weighted images and showed marked atrophy and fatty infiltration on T1-weighted images
(Fleckenstein et al, 1993; Uetani et al, 1993). In some patients, MRI findings became normal
after recovery of the paralysis and reinnervation (Fleckenstein et al, 1993; Uetani et al, 1993).
In a study describing MRI findings in two patients with perineural spread of tumours, T2
prolongation was seen in facial muscles, suggesting denervation changes (Fischbein et al,
2001).
Denervated microvascular free flaps have been studied with MRI (Hudgins et al, 1994; Salmi
et al, 1995; Wester et al, 1995; Chong et al, 2001). Nerve supply to the microvascular flap is
surgically interrupted, leading to muscle atrophy, which results in a predominantly fatty
appearance of the flap on MR images (Wester et al, 1995; Salmi et al, 1995). Immediately
after the operation, the microvascular flaps demonstrated mostly intramuscular oedema and
the volume of the flaps increased by 2 weeks postoperatively. At 6 months, the flaps had
returned to their initial volumes with evident fat degeneration (Salmi et al, 1995). In a study
by Chong with 20 free flaps and seven pedicled flaps, there was no statistically significant
difference between pedicled and free flaps in terms of enhancement, T2 signal or tendency to
appear striated. Despite denervation, most of the flaps in this series did not atrophy over three
years follow-up time (Chong et al, 2001).
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5. Morphology of skeletal muscle tissue
Skeletal muscles generate force and movement, and are under voluntary control. Skeletal
muscle is composed of specialized cells called myofibers. They are separated by a sheath
termed endomysium. In turn, myofibers are arranged in fascicles which are surrounded by a
connective tissue layer called perimysium. The whole muscle is covered in a third connective
tissue sheath, epimysium. Myofiber is found to be composed of parallel myofibrils. The
myofibrils lie within the sarcoplasm which also contains cellular organelles such as
mitochondria, endoplasmic retinaculum, t-tubules, ribosomes and glycogen particles (Figure
5). The basic contractile unit within each myofibril is called a sarcomere, consisiting of thin
and thick filaments that are made of actin and myosin proteins, respectively, and other
myofibrillar proteins accounting for the striated appearance of skeletal muscle.  Each motor
neuron innervates a group of myofibers which together form a motor unit. Thus, each fiber
within a motor unit is innervated by a single alpha motor neuron which terminates in a
neuromuscular junction, also called a motor end plate. The myofibers of each motor unit
contract simultaneously (Rudkin et Miller, 2006).
Skeletal muscle in mammals consists of different types of fibers. The functional demand of a
muscle determines the fiber types and fiber type distribution in a muscle. There are slow-
(type 1) and fast- (type2) twitch types of fibers. Type 2 fibers are further subdivided into
groups type 2A (fast oxidative) and types 2B and 2X (fast glycolytic). In humans, most
muscles contain a mixture of fiber types, and one fiber type can predominate in some
muscles.(Rudkin et Miller, 2006; Äärimaa, 2006).
Figure 5. Structure of myofiber (reproduced with the permission of M. Kääriäinen, 2001)
5.1. Denervation and reinnervation changes in skeletal muscle tissue
Alterations in neuronal input, vascular supply, resting length and muscle activity will produce
alterations in muscle morphology (Guelinckx et al, 1997).
Experimental studies have shown that both muscle transfer and denervation cause trauma to
muscle tissue. It is established that the morphology, physiology and biomechanical
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characteristics of muscle fibers are determined by the type of innervating motor neuron (Cote
et Faulkner, 1986).
The trophic status of the muscle is directly related to the integrity of the motor nerve, so it is
obvious that nerve injury will produce changes in the physiological, morphological and
histochemical characteristics of the affected muscle.
The denervation of muscle results in muscle atrophy, as manifested by a reduction in muscle
fiber size and number, and at the same time an increase in connective tissue (Zhang et al,
1997). The mass of the denervated muscles usually decreases to approximately 30 percent of
the initial mass. The motor nerve is able to arrest the atrophic changes of denervated muscle
and preserve the muscle mass to about 90 percent of its initial weight (Zhang et al, 1997). The
principal morphological change of denervated muscle fibers is shrinkage of the cross-
sectional area of the fibers. (Carlson et Faulkner, 1983; Carlson et Faulkner, 1988; Carlson et
Faulkner, 1989; Schmalbruch et al, 1991; 1994). Also fiber type grouping and changing the
relative number of the fiber types after the denervation and reinnervation are well known
characteristics (Guelinckx et al, 1997; Jakubiec-Puka et al, 1992). Microscopic changes in
denervated myofibers closely resemble those in immobilized muscles (Cooper, 1972) as
disuse alone can cause atrophy, as seen with extremity cast immobilization and tendon
transsection (Kauhanen et al, 1996).
Skeletal muscle is capable of extensive regeneration after injury. Satellite cells, located
between the basement membrane and plasma membrane of the myofiber, are responsible for
the regeneration process (Grounds, 1991). They are quiescent myogenic precursor cells,
which become activated following muscle injury. Satellite cells proliferate and differentiate
into myoblasts to fuse to myotubes and finally mature into adult muscle fibers (Bodine-
Fowler, 1994) Even without nerve supply, satellite cells can divide and form myotubes
(Schmalbruch et al, 1991). Reinnervation, however, is necessary for the new fibers to mature
(Schmalbruch et Lewis, 1994; Rantanen et al, 1995). In muscle lacking contractile stimuli or
complete innervation, repeated attempts at regeneration will eventually cause exhaustion of
the myogenic precursor cells, i.e. satellite cells (Campion, 1984; Schmalbruch et Lewis, 1994;
Rantanen et al, 1995; Jejurikar et al, 2002). Satellite cell depletion, in turn, causes impairment
of contractile function and loss of the ability to repair muscle fibers (Schmalbruch et Lewis,
1994; Jejurikar et al, 2002).
A key determinant of the success of both the regeneration and the subsequent innervation of
muscles is the basal lamina. The basal lamina sheaths surrounding each muscle and nerve
fiber provide a mechanical scaffold and supporting matrix that promotes interactions between
muscle and nerve cells during regeneration. In addition to its general supporting role during
regeneration, the basal lamina acts as substrate for the attachment of important signaling
molecules at the neuromuscular junction. The most important of these is agrin. Agrin survives
the regeneration of both nerve and muscle cells, and serves to promote and coordinate
effective reconstruction of neuromuscular junctions on the regenerated muscle fibers (Slater et
Schiaffino, 2008).
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5.2 Morphology of free microvascular muscle flaps
The issue of morphological changes in free flaps is more complicated than in denervated
muscle as, with the flaps, there is also the disturbed vascularity, decreased muscle tension and
disuse of the muscle flap. In general, it is believed that morphological changes in non-
reinnervated flaps are similar to those seen in denervated muscle tissue (Zhang et al 1997).
In a human study, mean muscle fiber diameter decreased significantly and muscle type 1
atrophy was dominant, increasing the percentage of type 2 fibers after the muscle transfer.
Fatty change and fibrosis were also present and they increased with the duration of follow-up.
(Kauhanen et al, 1998a; Kauhanen et al, 2004)  Predominant type 1 atrophy is reported also in
experimental  models (Roy et al, 1992).
Reinnervation can occur spontaneously from nerves in surrounding tissues, a phenomenon
called neurotization, in microvascular free flaps (Kauhanen et al, 2004). In human material,
satellite cells were found even 3-4 years after free flap transfer, indicating continuous
regeneration of the muscle (Kauhanen et al, 2004).
5.3 Morphology of free microneurovascular muscle flaps
In a large experimental study, the denervated, non-transplanted muscles which received both
motor nerve reinnervation and neurotization resulted in significantly preserved muscle mass
compared with the denervated control muscles. In transplanted gracilis free flaps, however,
only direct reinnervation with motor or sensory nerves resulted in improved bulk
preservation. Neither sensory nor motor neurotization was significantly effective in the free
flap model (Zhang et al, 1997).
In an experimental study on reinnervated prefabricated free flaps, a considerable amount of
muscle atrophy was present regardless of the extent of reinnervation (Kostakoglu et al, 1995).
In experimental data, it has been shown that fiber necrosis, degeneration and regeneration do
not occur to a significant extent after microneurovascular transfer (Guelinckx et al, 1988;
Yoshimura et al, 2006).
In a study by Frey with seven facial reanimation patients, the morphology of
microneurovascular muscle grafts correlated well with the functional result. Muscle fiber type
distribution showed a strong influence of the quality of the nerve used for the crossover
innervation. Morphology of the muscle flaps showed variation: in some biopsies the muscle
fibers were regular and scar tissue was scarce wheras in others atrophic fibers were
predominant (Frey et al, 1991).
Yoshimura et al. showed in a series of nine patients that there were regularly distributed fibers
and fiber type grouping indicating successful reinnervation after microneurovascular muscle
transfer. Satellite cells were responsive even ten years after the microneurovascular muscle
transfer, suggesting that muscle regeneration might still take place long after transfer even if
the muscle fiber area and diameter were similar to that of control muscles (Yoshimura et al,
1998).
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6. Degeneration and regeneration of the peripheral nerve
Peripheral nerve is composed of somesthetic and sympathetic sensory and motor fibers. The
nerves themselves are composed of axons which can be either myelinated or unmyelinated,
and are supported by Schwann cells. Endoneurium surrounds individual axons and their
Schwann cell sheaths and is predominantly composed of orderly oriented collagen fibers.
Next, the perineurium, formed from many layers of flattened cells (e.g. fibroblasts) and
collagen, surrounds groups of axons to form fascicles. Finally, epineurium, an outer sheath of
loose fibrocollagenous tissue, binds individual nerve fascicles into a nerve trunk. Peripheral
nerves are well vascularized by vessels in the surrounding tissue, penetrating the nerve and
continuing as capillaries within the supporting tissue of the nerve trunk. (Schmidt et Leach,
2003; Shenaq  et Kim, 2006).
In general, facial nerve behaves like any peripheral motor nerve in its capacity to regenerate
(Choi et Dunn, 2001). After nerve injury the, Wallerian degeneration takes place so that the
distal axon and myelin begins to degenerate, and finally debris is phagocytosed by
macrophages and Schwann cells (Choi et Dunn, 2001; Schmidt et Leach, 2003). In addition to
clearing axonal and myelin debris, Schwann cells produce cytokines and many neurotrophic
factors and their receptors, including NGF and p75NGFR,  thus enhancing axonal growth
(Frostick et al, 1998; Choi et Dunn, 2001; Schmidt et Leach, 2003). After debris clearance,
regeneration begins from the proximal surviving part of the severed nerve to the distal stump.
Schwann cells ensheath regenerating axons and later myelinate them (Choi et Dunn, 2001).
6.1 Histological findings in nerve grafts
Nerve grafting or a nerve conduit between the ends of the transected nerve is required when
the gap between the stumps of the nerve is so long that suturing them together would lead to
harmful tension and thus impair regeneration (Millesi et al, 1972; Terzis et al, 1997). In
humans, usually in  nerve gaps more than 2.0 cm to 2.5 cm, nerve grafting needs to be
considered (Millesi, 1987). Axons in  these autogenous  nerve grafts will undergo Wallerian
degeneration but retain the critical connective tissue scaffold for ingrowing axon sprouts
(Millesi, 1991).
There has been a lot of experimental work studying the effects of other materials serving as
conduits than autologous nerve grafts, but so far none of the materials studied have either
matched or exceeded the performance of natural nerve grafts (Schmidt et Leach, 2003).
Some experimental work has aimed to characterize the morphology of free nerve grafts and
attempted to clarify the factors which influence the final function of microneurovascular
muscle flaps (Frey et al, 1992; Koller et al, 1993; Frey et al, 1998). In a study in sheep, the
mean diameter of axons in nerve grafts was about one-quarter of the mean diameter of axons
in the normal motor nerve. No clear correlation was found between the time from nerve
grafting to biopsy and the number of axons in the distal end of the nerve graft (Frey et al,
1992). However, there was an up to fourfold increase in the number of axons at the distal end
of the graft (Frey et al, 1992). In a rat model, cross-facial nerve grafts were examined
histomorphometrically, revealing decreased axon diameter and mean myelin area in the nerve
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grafts compared to control nerves (Thanos et Terzis, 1996). In this experimental study, there
was a positive correlation between number of axons in the graft and motor endplate counts in
reinnervated muscle. (Thanos et Terzis, 1996).
Previously, small numbers of human cross-facial nerve grafts have been evaluated
histologically showing increased fibrosis of the grafted nerve (Vedung et Olsson, 1982; Frey
et al, 1991; Frey et al, 1996). In a clinical study of five patients, a large number of
unmyelinated axons was seen in the distal end of sural nerve grafts, and the myelinization
increased as the time between nerve grafting and biopsy taking was up to one year (Vedung et
Olsson, 1982). In another series with seven patients, number of regenerated nerve fibers was
only 20 % of the original number of nerve fibers, and they were consistently thinner (Frey et
al, 1991; Frey et al, 1996). In a quantitative study on sural cross-over nerve grafts, myelinated
fibers remained small and the numbers of regenerating axons did not correlate with age nor
regeneration time (Jacobs et al, 1996).
6.2 Expression of P75NGFR in neural tissue
Nerve growth factor (NGF) was the first neurotrophic factor, isolated in 1951 from male
mouse salivary glands (Levi-Montalcini et Hamburger, 1951), but much later it was believed
to be of great importance in the adult nervous system (Hefti, 1986). NGF is expressed at low
levels in healthy peripheral nerve by Schwann cells and is upregulated in the distal stump
upon injury (Saika et al, 1991). NGF promotes the survival and outgrowth in sensory neurons,
but its role in motor nerve regeneration is unsure (Tuszynski et al, 1996; Oudega et al, 1996).
So far, two distinct receptors have been identified for NGF: a low-affinity nerve growth factor
receptor (p75NGFR) and a high-affinity receptor (trkA) (Frostick et al, 1998; Choi et Dunn,
2001).
The trk family of receptor tyrosine kinases, (trkA, trkB and trkC) includes high-affinity
receptors with a high specificity for individual neurotrophins (Klein et al, 1991; Squinto et al,
1991).
P75NGFR binds to all neurotrophins and interacts with all receptors of the trk family
(Dechant et al, 1997). P75NGFR is expressed during early neuronal development, and is
thought to be important for motoneuronal survival during development (Boyd et Gordon,
2001; Dechant et Barde, 2002).
In the adult, p75NGFR is re-expressed in various pathological conditions including
mechanical trauma, focal ischaemia, stroke, epileptic seizures and Alzheimer’s disease
(Dechant et Barde, 2002). In experimental work, p75NGFR is markedly increased in
axotomized motoneurons (Ernfors et al, 1989; Rende et al, 1995; Gschwendtner et al, 2003)
or after spinal root avulsion (Wu et al, 2004).  In a study in rat, the expression of nerve growth
factor receptor was greatly increased after the sciatic nerve crush decreasing to control levels
by the time the motor function of the leg had been restored (Ernfors et al, 1989). In a more
recent study, the expression of p75NGFR was examined during peripheral transsection of the
facial nerve of adult mice. Axotomy led to a strong increase in p75NGFR immunoreactivity
on the injured and regenerating facial motoneurons and on denervated Schwann cells
(Gschwendtner et al, 2003).
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However, function of this receptor in normal adult motoneurons remains unknown (Ferri et al,
1998; Dechant et Barde, 2002). It has been suggested that p75NGFR participates in apoptosis
of motoneurons and Schwann cells (Ferri et al, 1998; Ferri et Bisby, 1999; Dechant et Barde,
2002; Boyd et Gordon, 2003;) but on the other hand, it has a role in the survival of
motoneurons by interacting with specific receptors (Ferri et al, 2002).
In a study using nerve grafting after spinal root avulsion in adult rats, all regenerating
motoneurons expressed p75NGFR while all motoneurons that failed to regenerate did not
express p75NGFR. (Wu et al, 2004). In another study on sciatic nerve transsection in rats, the
Schwann cells in the distal segment showed a prolonged period of NGF and p75NGFR
expression (Liu et al, 1995).
6.3.Expression of VEGF in neural tissue
Vascular endothelial growth factor, VEGF, has a predominant role in the formation of
vascular structures (angiogenesis) during embryonic development and in numerous
pathological conditions (Carmeliet et Storkebaum, 2002; Storkebaum et al, 2004). It was
discovered over 20 years ago (Senger et al, 1983) as a vascular permeability factor, and was
later cloned and termed vascular endothelial factor by Ferrara et al. (Ferrara et Henzel, 1989).
VEGF binds the receptor tyrosine kinases Flt-1 (VEGFR-1) and Flk-1 (VEGFR-2/KDR).
Neuropilin-1(NP-1) is a specific receptor to a certain VEGF isoform (VEGF 165) and a co-
receptor of Flk-1 (Soker et al, 1998). More recent findings reveal that VEGF has direct effects
on neural cells (Sondell et al, 1999a; Hobson et al, 2000; Carmeliet et Storkebaum, 2002;
Storkebaum et al, 2004).
Hobson showed that neovascularization preceded axonal regeneration in rats in an acellular
nerve conduit composed of orientated fibronectin mat. In that model, nervous tissue was
absent from avascularized areas whereas Schwann cells and axons extended together and
were most numerous in well vascularized areas (Hobson et al, 1997). Regenerated nerve
fibers were found more frequently in the vicinity of the blood vessels also in an earlier study
(Weis et Schröder, 1989).
Experimental work, both in vitro and in vivo, has shown that VEGF and its receptors exist in
neural cells (Sondell et al,1999a; Sondell et al,1999b; Oosthuyse et al, 2001; Islamov et al,
2004). In adult mouse spinal cord, VEGF was produced by motor neuron itself or nearby
astrocytes, and Flk-1 and NP-1 were co-expressed in motor neurons (Oosthuyse et al, 2001).
Sondell and coworkers demonstrated expression of VEGF in cultured mouse nervous tissue,
and also expression of Flk-1 receptor in dorsal root ganglia and Schwann cells (Sondell et al,
1999a). In an experimental model, mice were submitted to experimental nerve crush injury,
and  the expression of VEGF and Flt-1 was increased compared to controls. However, VEGF,
Flk-1 and Flt-1 were also expressed in normal mouse sciatic nerve although in lesser amount
(Islamov et al, 2004).
The neurotrophic effect of VEGF would appear to be mediated mostly through the receptor
Flk-1 (Zhang et al, 2003). In abundant studies, VEGF has been added to neural structures to
elucidate its effect on nerve regeneration (Sondell et al, 1999a; Sondell et al, 1999b; Hobson
et al, 2000; Rovak et al, 2004b). Added VEGF increased the number of Schwann cells and
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enhanced axonal regeneration in cultured mouse dorsal root ganglia (Sondell et al, 1999a). In
one study, VEGF was added to acellular nerve conduits with variable results. The total
number of axons was increased at the proximal nerve gap coaptation site, but there were
relatively few axons at the distal coaptation site (Rovak et al, 2004b). In another study, VEGF
stimulated the outgrowth of blood vessels and Schwann cells but not axons in acellular nerve
conduit (Sondell et al, 1999b), and in yet another study, addition of VEGF to a silicone nerve
chamber resulted first in increased blood vessel formation and later in increased axonal
regeneration and Schwann cell migration (Hobson et al, 2000).
Samples are taken rarely from human neural tissue or nerve grafts, so the literature concerning
the expression of VEGF in neural tissue is mostly based on experimental work. However, in
one clinical study, improvement in chronic ischemic neuropathy after intramuscular VEGF
gene therapy in patients with critical lower limb ischaemia was reported (Simovic et al, 2001).
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AIMS OF THE STUDY
In this thesis, cross-over nerve grafts and microneurovascular muscle flaps in humans are
examined in the clinical context of surgical treatment after severe facial paralysis.
The specific aims of the present study were:
1. To report the long-term functional outcome of facial reanimation using two-stage
procedure and to find out which factors influenced the final result.
2. To describe the maintenance of muscular structure and volume of microneurovascular
flaps after facial reanimation  by MRI.
3. To characterize regenerative structural changes in microneurovascular muscle
transplants after facial reanimation using immunohistochemical methods.
4. To document the changes in nerve morphology in a large material of human cross-
facial nerve grafts before free muscle transfer.
5. To characterize the expression of specific growth factors and their receptors in human
cross-facial nerve graft.
6. To compare the morphological findings of muscle and nerve with the function of the
transplanted microneurovascular muscle flap.
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MATERIAL AND METHODS
1. Patients (Studies I-V)
This thesis comprise a total of 37 patients who presented with complete, long-lasting
unilateral facial paralysis between 1986 and 2004 in Helsinki University Hospital. Twenty-
seven patients (study I) responded to an invitation to attend a clinical evaluation including an
interview and a video recording. Fifteen patients of the 27 were able to participate in MRI
study (study II).  The etiology of the paralysis of 37 patients (study IV) is presented in Table
3. Etiology of the specific subgroups of patients in studies I to IV is presented in original
articles. The duration of the facial paralysis preoperatively ranged from 1 to 41 years. The age
of patients varied from 7 to 65 years at the time of operation. Only one patient was a child, a
girl aged 7 years.
Table 3. Etiology of facial paralysis of 37 patients (Study  IV)








Total       37
Seventeen (Study III), 37 (Study IV) and 35 (Study V) patients participated in
immunohistochemical studies.
All patients were operated on by a senior surgeon using a standard two-stage method. In the
first stage, an 18-20 cm long sural nerve graft was harvested and transplanted under the chin
to connect the healthy side to the preauricular area on the paralysed side. Large buccal
branches of the facial nerve (8-12 axons) on the healthy side were sacrificed, and the nerve
graft was coapted epineurially with 10/0 sutures. Eight months (range 4-20mos) after the
nerve transplantation, the microneurovascular muscle bundle was grafted. The size, length,
and total volume of the graft were carefully planned. Blood vessels were anastomosed to the
facial artery and vein under the chin. The nerve of the muscle was coapted to the nerve graft
with epineurial sutures. From 6 to 8 months later, patients started to train the muscle
transplant. They were advised to exercise their mimic muscles in front of the mirror several
times a day.
The sural nerve was used as a cross-facial nerve graft in every case. Three different muscles:
gracilis, latissimus dorsi, serratus anterior were used as a microneurovascular muscle flap.
To evaluate which demographic and clinical factors influenced the final functional outcome
of facial reanimation the patients’ hospital charts were reviewed retrospectively. The data of
characteristics of all the patients and their operations in individual studies (I-V) is presented in
Table 4.
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After transplantation of the muscle, other procedures including tarsorraphies  (n=16) and
forehead procedures (n=4) were needed 53 times in 21 patients (study I). Secondary
operations involving the transplanted muscle totalled 32 facial lifts including correcting the
position of the free muscle in 19 patients during follow-up (study I).
Table 4. Characteristics of patients and operations
2. Evaluation of functional outcome (Study I)
Twenty-seven patients were videorecorded at rest, while speaking, and while making a
number of voluntary movements to show mimic muscle function. The functional outcome of
the operation was illustrated by the amount of facial dysfunction remaining. It was graded
objectively during the interview by a single physician on a scale from 1 to 6 as described by
House, Table 2 (House, 1983). These grades were later combined with those obtained from
the videotapes. The House scale was modified by disregarding the function of the forehead, as
in these operations no muscle was transferred to the forehead area.
In interviews, satisfaction of the patients was measured by asking them how the operations
had affected their quality of life. The answers were graded on a scale from 1 to 4:
1) quality of life considerably better after the operations
2) quality of life better after the operations
3) quality of life unchanged after the operation
4) quality of life poorer than before the operations
They were also asked to estimate how much time they spent practicing facial movements after
they had been asked to train their facial function. The amount of practice was graded on a
scale from 1 (none) to 4 (several times a day).
Study I Study II Study III Study IV Study V
Number of patients 27 15 17 37 35
Age at the time of mnv muscle 7-65y 7-63y 7-62y 7-65y 7-65y
transfer mean 41y mean 36y mean 41y mean 38y mean 38y
Time between nerve cross-over 4-20m 4-19m 4-20m 4-20m 4-20m
and mnv muscle transfer mean 8m mean 8m mean 7m mean 8m mean 8m
Number of patients available for 27 15 14 24 24
evaluation of functional outcome
Follow-up time 2-15y 3-14y 2-15y 2-15y 2-15y
mean 8,5y mean 7y mean 8 mean 8,5y mean 8,5y
Time between muscle transfer 1-10y 1-10y 1-10y
and muscle biopsy mean 2,7y mean 2,7y mean 2,7y
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3. Magnetic resonance imaging (Study II)
Fifteen patients underwent MRI with a 1.5 T unit (Sigma LX, General Electric Medical
Systems, Milwaukee, WI) using a standard head coil. The sequences used in this study were
axial T2-weighted fast spin echo, coronal and oblique coronal T1-weighted spin echo, and
oblique coronal T2 weighted fast spin echo with fat saturation. Axial and coronal images, the
oblique coronal images and coronal T1-weighted spin echo images (TR 440 msec/ TE 21
msec, matrix 256x 224, field-of view 18 cm, slice thickness 3 mm) were used to align with
the expected course of the free flap, i.e. from the junction of the zygomatic bone and arch to
the corner of the mouth. Owing to the small cross-sectional area of the flaps, images
perpendicular to the long axis of the flap were not useful in the analysis. Images paralleling
the flaps were therefore used in the analysis.
The MR images were viewed on a PACS workstation and evaluated by two investigators
blinded to the clinical results. The free flap area of each slice was defined manually (region-
of-interest method) from the oblique coronal T1-weighted images, and the area was calculated
using the software (AGFA Impax 4.1) provided with the workstation. The volume of the free
flap was then calculated from the formula
Volume = (Area 1 x thickness of a MRI slice 1) + (area 2 x thickness of a slice 2)+… + (area n
x thickness of a slice n), where n is the last slice to be calculated.
The maximum thickness of the muscle was also marked. The muscle structure of the free
flaps was semi-quantitatively assessed on a scale from 1 to 4 by judging the appearance of the
muscle. Grades were from normal or almost normal muscle structure (grade I) to fatty-
infiltration (grade II) or severe muscle atrophy and fibrosis (grade III). Grade IV was recorded
in one case in which no muscle at all could be identified.
The initial weight of the flap (n=10) ranged from 20 to 75g. The original volume of these free
flaps was calculated from the formula:
Original volume = original weight of the flap (g) / muscle density (g/cm3), assuming the
muscle density of 1.056 g/cm3 used for mammalian muscles  (Lieber et Frieden, 2001).
4. Histology and immunohistochemistry (Studies III-V)
Eighteen muscle biopsy samples (including biopsies at two different time points in one
patient) were taken from the microneurovascular muscle grafts during secondary refinement
procedures (Study III). Routine histological analyses with van Gieson staining were
performed on all sections both in nerve and muscle samples (Bancroft et Stevens, 1977).
The muscle samples were fixed in 4% buffered formaldehyde, embedded in paraffin, cut into
5 µm thick sections, and mounted on slides. The deparaffinized sections were pretreated for
antigen retrieval (Von Boguslawsky, 1994) as shown in Table 5. Thereafter endogenous
peroxidase activity was inhibited with 0.5% hydrogen peroxide in absolute methanol for 30
minutes.
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Immunohistochemical stainings for muscle biopsies were performed with a Techmate 500
Immunostainer (Dako, Santa Barbara, CA, USA) using a CEM-mate visualization kit with
DAB as chromogen (Dako, Glostrup, Denmark). Pretreatment with normal horse serum for 15
minutes was used to block non-specific adherence. The sections were then incubated with the
diluted primary antibodies (Table 5). S-100 was used to indirectly detect the reinnervation in
muscle flap by visualizing the Schwann cells, MIB-1 as a marker for cell proliferation in
skeletal muscle and Myosin Heavy Chain (fast) to identify type 1 and 2 fibers. After the
addition of secondary antibodies and visualization, the sections were lightly counterstained in
Mayer´s hematoxylin and mounted in Aquamount (BDH Ltd, Poole, UK). In negative
controls, PBS was substituted for the primary antibody.
Thirty-seven nerve graft biopsies (Study IV) were taken at the same time as the
microneurovascular muscle was transferred. The nerve graft biopsies were taken from the
distal end of the sural nerve graft cutting away the distal 3-4 mm to avoid the scar artefact,
and the study sample was the next 5 mm of the sural nerve graft. Five healthy sural nerve
samples harvested at cross-facial nerve grafting served as control nerve samples. In study V,
we could use 35 nerve graft samples.
The nerve graft samples (studies IV-V) were fixed in 4% buffered formaldehyde, embedded
in paraffin, cut into 5-µm thick sections, and mounted on slides. The deparaffinized sections
were pretreated for antigen retrieval (Table 5). Thereafter endogenous peroxidase activity was
inhibited with 0.5% hydrogen peroxide in absolute methanol for 30 min, and the sections
were washed with phosphate-buffered saline (PBS). Non-specific adherence was blocked by
pretreatment with normal horse serum for 15 min. The sections were then incubated with the
primary antibodies (Table 5).
In study IV, Neurofilament-200 antibody reveals the number of viable axons, and S-100
protein visualizes Schwann cells (Vanstapel at al, 1986). Monoclonal antibody to human
Nerve Growth Factor Receptor p75, clone 8211 (Boehringer Mannheim, Germany) was used
to detect these receptors.
In study V, monoclonal anti-human endothelial cell antibody (CD-31) was used to detect the
density of vascular structures in nerve graft samples and to identify the vascular structures
within the nerve tissue (Table 5). The angiogenic capacity of originally avascularized nerve
grafts was identified with VEGF, Flt-1 and Flk-1 (Table 5).
After addition of secondary antibodies and performance of the chromogenic reaction (AEC,
Elite mono kit), the sections were lightly counterstained in Mayer’s hematoxylin and mounted
in Aquamont. In negative controls, PBS was substituted for the primary antibody.
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Table 5. Pretreatments and primary antibodies for immunohistochemistry (Studies III-
V)
Primary antibody Pretreatment Dilution Source
Ki-67 citrate buffer and microwave 1:50 Immunotech, France
clone MIB-1
Monoclonal
S-100 none 1:20000 Dako, Denmark
Polyclonal
Myosin Heavy Chain (fast) none 1:30000 Sigma, Germany
Monoclonal, clone MY-32
NF-200 none 1:200 Boehringer, Mannheim,
Monoclonal Germany
p75NGFR protease type VIII 1:10 Boehringer, Mannheim,
clone 8211 Germany
Monoclonal
CD-31 0.01% protease +37C 1:100 Dako, Denmark
Monoclonal
VEGF citrate buffer and microwave 1:100 BD PharMingen, Europe
clone G153-694
Monoclonal
Flt-1 citrate buffer and  microwave 1:50 Santa Cruz Biotechnology,
(H-225) Europe
Rabbit polyclonal




4.1 Quantification of immunohistochemistry (Studies III-V)
The histological sections were analyzed by two independent observers without prior
knowledge of the clinical data of the patients.
In study III, reinnervation of muscle flaps was detected indirectly immunohistochemically by
visualizing Schwann cells with S-100 protein (Vanstapel et al, 1986). The density of
immunopositive Schwann cells in eight randomly chosen microscopic fields in three
randomly chosen sections was assessed microscopically. Due to the size of the tissue samples,
all pertinent fields of the sample were covered. Each specimen was graded semiquantitatively
according to the method of Madsen (Madsen et al, 1996) on the following scale from 0 to 3:
0) no S-100 immunopositivity,
1) mild S-100 immunopositivity,
2) moderate S-100 immunopositivity,
3) strong S-100 immunopositivity.
In study III, the monoclonal antibody MIB-1, which recognizes Ki-67 antigen, was used as a
marker for cell proliferation in skeletal muscle. MIB-1 recognizes the antigen in
formaldehyde fixed tissues and has been used to detect dividing satellite cells (Kauhanen et al,
1998b). A number of MIB-1 stained nuclei were located clearly outside the basal lamina of
the muscle fiber, indicating that they were not satellite cells but belonged to a population of
dividing inflammatory cells, fibroblasts, or endothelial cells seen in these areas. The latter
cells were evaluated separately. In a few cases, it was difficult to define the location of the
MIB-1 positive nuclei in relation to the myofiber basal lamina. To identify the basal lamina
more precisely, such sections were double-stained with a modified reticulin stain according to
Gordon and Sweet´s method, highlighting the basal laminae (Von Boguslawsky, 1994). A
semiquantitative scoring system to classify the number of satellite cells and other mitotically
active cells was used on a scale from 0 to 3:
0) no satellite cells,
1) 1-5 cells/ section,
2) 6-10 cells/ section,
3) 10+ cells/ section.
In study IV, the number of NF-200 immunopositive axons in a cross-section of the nerve graft
was recorded as the percentage of the number in the control samples.
In study V, the number of vascular structures inside the nerve graft was identified and
calculated in CD-31- stained cross-sections of the nerve graft. Manual calculations were made
through a scoring grid amounting to 0.25 mm2 on the section. Several pertinent fields per
section were calculated to enable comparison between specimens. The results present the
number of vascular structures per unit area.
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Each specimen stained for p75NGFR, VEGF, Flt-1, Flk-1 (Studies IV-V) was graded
semiquantitatively according to the method of Madsen (Madsen et al, 1996) on a scale from 0
to 3:
0) no antibody expression,
1) mild immunopositivity in specific antibody,
2) moderate immunopositivity,
3) strong immunopositivity in neural structures in nerve graft samples.
5. Morphometric analysis (Study III)
Morphometric analyses of muscle fiber diameter and fiber type distribution were performed.
Several microscopic fields of transverse muscle sections stained with the van Gieson
technique and for Myosin Heavy Chain (fast) were analyzed with a Leitz Neopromar light
microscope. Images of the sections were captured to a Macintosh computer by Adobe
Premiere 4.2 software, after which the smaller diameters (Dubovitz, 1985) from a minimum
of 200 fibers in each case were pointed at manually with the mouse cursor and processed by
Paint Pro Shop 6 (Compuserve Graphics Interchange) and Lihis (Jouko Pesonen 1998)
computer programs. The muscle measurement program provides atrophy and hypertrophy
factors for each sample. These factors express the number of abnormally small and
abnormally large fibers in each sample. In normal adult muscle the atrophy factor has an
upper normal limit of 125 and the hypertrophy factor an upper limit of 200 (Kauhanen et al,
1998a).
The extent of fatty change and fibrosis in the flaps was assessed with a semiquantitative
method that graded the changes on a scale from 0 to 3.
6. Statistical analysis (Studies I-V)
In studies I –V Ordinal regression was fitted with the Statistical Package for the Social
Sciences (SPSS) Polytomous Universal Model (PLUM). For univariate analysis we used the
Kruskal-Wallis test (Studies I-III), Pearson and Spearman´s correlation tests (Studies II, IV,V)
and Fisher´s Exact test (Studies IV- V). In multivariate analysis the complementary log-log-
function (Studies I-III) and negative log-log function (Study II) were used.
Probabilities of less than 0.05 were accepted as significant (Studies I-V).
Written consent was obtained from each patient and the study was approved by the Ethics
Committee of Helsinki University Hospital.
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RESULTS
1. Long-term functional outcome of facial reanimation (Study I)
Almost two thirds of the patients achieved a result defined as only mild or moderate
dysfunction (grades II-III) of facial movement. In one third of the patients, dysfunction was
graded as moderately severe (grade IV) and in 10% as severe (grade V). None of the patients
had retained total facial paralysis postoperatively (grade VI). The long-term functional
outcome measured as the state of mimic function by House scale is summarized in Table 6.
In statistical analysis, the time period gone after facial reanimation made a difference on the
final functional outcome, the longer the follow-up time after the muscle transplantation the
weaker was the muscle function (p=0.003) as presented in Fig. 6.
In addition, correlations were studied between functional outcome and patients’ age and sex,
body mass index (BMI), smoking habits, alcohol consumption, dominant hand, aetiology and
side of the palsy, duration of palsy, time interval between the two operations, duration of
operation and intraoperative ischaemia, number of primary complications, and number of
secondary procedures. None of these factors correlated with the functional result. None of the
different donor muscles had any significant effect on final functional outcome.
The patients estimated the amount of time they had spent on mimic practice after the muscle
had been transplanted. The amount of practice did not correlate with the final functional
result.
Twenty-one patients (78%) thought that their quality of life had improved after the
microneurovascular muscle transplantation but six (22%) considered that the reanimation had
had no effect.  The degree of satisfaction correlated with a good final functional result, (p=
0.008).
Table 6. Functional outcome as the postoperative state of mimic function graded according to
House (House, 1983), Study I.




IV Moderately severe 8
V Severe 3
VI Total paralysis 0
N=27
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Figure 6. The relation between the duration of follow-up time (years) and the grading of
patients’ mimetic function. The solid bars indicate the median and the error bars the range.
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2. Magnetic resonance imaging of microneurovascular muscle flaps (Study II)
The muscle structure appeared normal in almost half of the patients, and fat infiltrated in
another six patients (Table 7). In one patient the muscle flap could not be identified, probably
due to the originally small size of the flap (20 g at transfer).
Table 7. Grading of muscle structure in MRI.
Grade Number of patients          Follow-up time after muscle transfer
I. Normal or almost normal muscle structure          6 (40%)          Mean 4y, (3-5y)
II. Muscle infiltrated with fat          6 (40%)          Mean 10y, (3-14y)
III. Severe muscle atrophy and fibrosis          2 (13%)          Mean 11y, (9-13y)
IV. Muscle could not be identified          1 (7%)          3y
The maximum thickness of the muscle flap ranged from 0.47 cm to 1.79 cm, average 0.95 cm.
At the time of muscle transfer, the calculated volumes of the flaps (n=10) ranged from 18.9 to
71.0 ml, average 44.9 ml. In five patients, the weight of the muscle flap was unknown. At the
time of evaluation the volumes of the flaps (n=9) ranged from 5.8 to 18.8 ml, average 10.2 ml.
In seven patients, data on muscle volume both at the time of muscle transfer and at the time of
MRI evaluation were available; the average loss of volume was 38.1 ml, ranging from 22.0 to
54.7 ml. In these patients, approximately 20% (range 13% to 23%) of the original volume of
the muscle flap was seen in MRI, which means 80% loss of muscle volume. The average
follow-up period for these patients was 3.9 years.
The muscle function was regarded as good in ten patients out of fifteen comprising mild or
moderate dysfunction (House scale II to III) of facial movements. Five patients had
moderately severe dysfunction (House scale IV) and none had severe dysfunction or total
paralysis after reanimation.
Normal muscle structure of the microneurovascular flap in MRI correlated with good mimic
function after reanimation (correlation coefficient 0.59, p=0.019) as presented in Figure 7.
The time period elapsing between facial reanimation and evaluation was associated with the
final functional outcome and the MRI grade; the longer the follow-up time after the muscle
transplantation, the weaker was the muscle function (p=0.023) and the poorer was muscle
structure in MRI (p=0.019).
The patients estimated the amount of time they had spent on mimic practice after the muscle
transplantation. Frequent practice was associated with higher muscle volume measured in
MRI. Practice, however, did not influence the MRI grade of muscle structure or the functional
outcome.
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Correlation studies were performed between the MRI grading of muscle structure and the
muscle volume both at the time of the transplantation and at the time of evaluation, the
patients’ age and sex, BMI, intraoperative ischaemia and the number of secondary procedures.
None of the above-mentioned factors correlated with the MRI grade or the long-term result of
facial reanimation. The effect of different donor muscles was also studied statistically and no
differences between the muscles were found in this patient series.
Figure 7. Correlation between the clinical outcome and MRI grading
Correlation between the clinical



















3. Morphology of free microneurovascular muscle flaps (Study III)
The morphology of the control muscles was normal. Muscle biopsies performed 1-10 years
after the second-stage operation showed a great variation in muscle fiber diameter between
the 17 patients. The mean muscle fiber diameter was 38  (range 14-70 m), indicating a
40% decrease compared with control values. In statistical analyses, smaller mean muscle fiber
diameters of each individual correlated with prolonged intraoperative ischaemia (p = 0.04).
Atrophy tended to be more severe in the serratus than in the other muscles (ns).  The extent of
fatty change and fibrosis ranged from minor to very severe as presented in Table 8.
In samples taken 1-10 years after surgery, muscle atrophy was not fiber type specific and the
mean percentage of type two fibers was not different from that of control samples. Fiber type
proportion was defined as the percentage of fast-twitch type 2 fibers. These showed
considerable individual variation with an average value of 56%. In four patients, muscle
morphology was virtually normal. In another four, the fiber type grouping typical of
reinnervated muscle after denervation was detected. Statistical analysis showed that the long-
term functional outcome was better in patients with a preponderance of fast fibers in their
muscle grafts (p=0.03).
In 60% of the samples, signs of ongoing muscle regeneration through activation of satellite
cells were still evident. In our patient series the proliferative activity of satellite cells  declined
with prolonged follow-up time (ns). The control muscle samples taken during the operation
showed no proliferative activity. In some patients, proliferative activity was detected in nuclei
outside the myofiber basement membrane 3-4 years after surgery. These cells included
fibroblasts, inflammatory cells and endothelial cells.
After 1-10 years’ follow-up, the intramuscular expression of S-100 protein indicative of
reinnervation was visibile in all available samples as presented in Table 8. No correlation was
found between innervation density and clinical factors in any of our patients (p>0.05). In
control samples, muscle innervation was unaltered.
In this patient series, neither muscle morphology nor innervation were statistically affected by
gender of the patient, age at the time of free muscle transfer, body mass index (BMI),
smoking, time between the two operations, weight of muscle transplant, or the occurrence of
primary complications.
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Table 8. Fatty change, fibrosis and reinnervation of free mnv muscle flaps (Study III)
Key to scoring of fatty change and fibrosis: - none, + little, ++ moderate, +++ severe
Key to scoring of reinnervation: 0 no, 1 mild, 2 moderate, 3 strong
Patient Fatty Fibrosis Reinnervation
Change
1. + +++ specimen lacking
2. ++ ++ 1
3. - +++ 2
4. ++ +++ 3
5. + ++ 2
6. + ++ 2
7. ++ ++ 2
8. ++ + 1
9. - - 3
10. + + 1
11. + +++ 3
12 ++ + specimen lacking
13.a + + 3
13.b + - 3
14. - + 3
15. +++ + 1
16. ++ ++ 3
17. ++ + specimen lacking
46
4. Expression of p75 Nerve Growth Factor Receptor in nerve grafts (Study IV)
In light microscopy, the grafted nerves were characterized by thickening of the epineurial and
perineurial sheaths and fibrosis, notably in the endoneurial space. There was also perineurial
invasion of inflammatory cells. In nerve graft biopsies, the mean number of axons expressing
NF-200 amounted to 38% (range 6-81%) of that in the control samples. Axons were
consistently thinner than in the control samples, and the thin axons were occasionally
arranged in clusters.
Immunopositivity for S-100 indicating Schwann cells was seen in all sections. S-100
expression was stronger along the thicker axons than in samples with predominantly thin
axons (ns).
In all nerve grafts studied, the expression of p75NGF receptor was clearly increased at the
distal ends and was located along the axons. Table 9 illustrates the distribution of p75
expression. In our five control samples, immunopositivity for p75NGF receptor was very low
or absent.
Table 9. Expression of p75NGFR in nerve grafts.







Statistical analysis showed that expression of p75NGFR was significantly lower in older than
in younger people, p=0.003, Figure 8. A younger age for the patient also correlated with a
higher number of viable axons at the distal end of the nerve graft (p=0.021).
A longer time between cross facial nerve grafting and biopsy sampling correlated strongly
with a higher number of viable axons, p=0.002, Figure 9. No such correlation was noted in the
time interval until biopsy and the expression of p75NGFR.
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Figure 8. Correlation between the age of the patient and the expression of p75NGFR.
Figure 9. Correlation between the amount of viable axons and length of time until biopsy of
the sural nerve graft. Number of NF-200 immunopositive axons in a cross-section of the
nerve graft is recorded as the percentage of the number in the control samples.
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There was an association between a high amount of viable axons in the grafted nerve and
dense reinnervation of the microneurovascularly grafted muscle (correlation co-efficient
0.511, p=0.074). The expression of p75NGFR correlated with neither the number of viable
axons at the distal end of the nerve graft nor the grafted muscle characteristics.
Of interest is that high expression of p75NGFR was often seen with better function of the
transplanted muscle  (p=0.087) as presented in Figure 10. No other of the above-mentioned
factors affected the mimic function of the muscle statistically. Thus, expression of p75NGF
receptor in the nerve graft is the only factor associated with good long-term mimic function of
the transplanted muscle in this Study IV.
Figure 10. Relationship between the expression of p75NGFR and the function of the










5. Expression of Vascular Endothelial Growth Factor and its receptors in nerve grafts
(Study V)
Numerous vascular structures were calculated in avascularized human nerve grafts 8 months
after grafting. With CD-31 staining, we found 166 vascular structures per unit area in
horizontal nerve sections, corresponding to values in control nerves. However, the variation
was wide within the samples, ranging from 78 to 267 vascular structures per unit area.
VEGF was expressed more often and with higher intensity in grafted than in control nerves.
Immunopositivity was most intense in axons in grafted nerves whereas in control nerves
(n=3) only the myelin sheaths were immunopositive. Intensity of immunostaining for VEGF
in nerve grafts (n=34) is shown in Figure 11. VEGF immunopositivity in nerve grafts and in
control nerves is illustrated in original article, Study V. Endothelial cells showed high
intensity of staining for VEGF in both grafted and control nerves, adding to the validity of the
staining method.
Figure 11. Intensity of immunostaining for VEGF in nerve grafts






















Grade 1Grade  0 Grade 2 Grade 3
Flt-1 receptor expression was seen in axons and perineurial structures and also in endothelial
cells in nerve grafts. Flt-1 receptor immunostaining intensity is presented in Figure 12. Flt-1
receptor staining in human nerve graft is shown in original Study V. In this staining our study
material was limited to 18 samples. In control nerves, Flt-1 immunopositivity was mostly low
in neural structures, whereas the vascular structures were clearly immunopositive.
50
Figure 12. Intensity of immunostaining for Flt-1 in nerve grafts.
Flt-1 expression in nerve grafts


















Immunopositivity for the Flk-1 receptor in neural structures (n=35) was found in only 50% of
the nerve graft samples, implying that half of the samples did not have staining capacity for
Flk-1 receptor. Staining intensity was mainly low, as presented in Figure 13.
Immunopositivity for Flk-1 in endothelial cells was clearly visible in nerve grafts. In control
nerves there was no immunopositivity in neural structures for Flk-1, whereas endothelial cells
in vascular structures did stain for Flk-1.
Statistical analysis revealed a slight association between a high number of vascular structures
(CD-31) and low immunopositivity in VEGF staining (ns). In our material, we found no
correlation between the expression of VEGF or its receptors and viable axons (NF-200) at the
distal end of the nerve graft. The expression of VEGF did not associate with the function of
the grafted muscle or with the expression of p75NGFR.
Figure 13. Intensity of immunostaining for Flk-1 in nerve grafts.
Flk-1 expression in nerve grafts

























Nearly thirty years of microsurgical experience in facial reanimation has contributed to our
knowledge of the factors that influence the functional and aesthetic outcome after surgical
treatment. However, the final functional outcome may unpredictably vary a lot among the
patients.
1. Evaluation of functional outcome in facial reanimation
Several grading systems have been developed to quantify the extent of facial paralysis and the
outcome of microneurovascular reanimation of the face (House, 1983; Murty et al, 1994;
Chee et Nedzelski, 2000; Kahn et al, 2001; Brenner et Neely, 2004; Harrison, 2005).
Many of them have been used successfully in one study, but the problem exists when several
studies are being compared each having an individual system of grading. Promising
computer-assisted methods for assessing mimic function have been developed (Frey et al,
1994; Frey et al, 1999; Sargent et al, 1998), but they require technical equipments compared
to the interview-based methods. In our study, facial dysfunction was measured by House’s
well-established standard grading system (House, 1983). The degree of dysfunction is clearly
defined on a scale from 1 to 6. The patients were assessed both live during the interview and
from video-recorded tapes illustrating mimic function at different sessions. Every face has a
range of dimensions, and a human observer can recognise the extent of a smile not
measurable in millimeters (Paletz et al, 1994). We chose the House scale because it is widely
used in evaluating the loss of facial function (Novak, 2004). The consensus scoring system
generated by the Fifth International Symposium on the Facial Nerve was based on the House
scale (Dellon, 1992), and it is also used more recently as in studies by Manni (Manni et al,
2001) and Malik (Malik et al, 2005).
Regarding clinical outcome after facial reanimation results vary considerably. Harii provided
a huge clinical data including 210 patients with cross facial nerve grafts and free muscle
transfer. In this series, half of the patients achieved natural or near-natural animation. The
other half had noted problems with excessive, contractions too strong or too weak, or
problems with muscle attachments. (in Swartz, 2003). In other studies with different
evaluation scales 42-51% of the patients had good or excellent results (Terzis et Noah, 1997;
O´Brien et al, 1990). In our clinical study, 60% of the patients had good functional result at
the time of evaluation, implying a quality of results similar to that of other studies. Our study
material, collected in small Finnish population, will always remain lower in the number of
patients than in other clinical studies conducted in large countries like USA (Terzis et Noah,
1997). In a small study, it is even harder to show any significant correlations, and in some
cases, there could be more associations with larger series of patients.
When we compare the results of different papers (O´Brien et al, 1990; Sassoon et al, 1991;
Terzis et Noah, 1997; Kumar et Hassan, 2002), factors such as the extent of the facial
paralysis and the great variation in duration of follow-up must be taken into account. In these
papers, follow-up times range from 7 months to 11 years, mean follow-up times being 2-4
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years, and only 34 to 68% of the patients had complete facial palsy. In our study, all the
patients had complete facial palsy. As our study was retrospective, the different patients were
assessed at different time points after muscle transplantation. However, the mean follow-up
period covered nearly 9 years, and was up to 15 years for some patients. These factors may be
of great importance when judging the outcome, as there was a clear correlation between
recent muscle transplantation and a good functional result in our study.
In other words, the older the transplant, the weaker was the muscle function. The better
outcome achieved in more recent cases may have been the result of increased experience and
improved technical skills on the part of the surgical team. Lack of muscle adaptation after the
muscle transfer could also influence the long-term result. As stated before if there are no
contractile stimuli or innervation is incomplete, the repeated attempts at regeneration will
eventually exhaust satellite cells (Schmalbruch et Lewis, 1994; Yoshimura et al, 1998).
Depletion of satellite cells impairs contractile function and the ability to repair tissue is lost
(Jejurikar et al, 2002). In our study, however, the activation of satellite cells was associated to
be time-dependent such that the longer the follow-up time, the fewer were the attempts at
regeneration shown by the expression of satellite cells. It is tempting to suggest that our
finding with the longer follow-up time connected with worse functional outcome can be
explained, at least on one side, by the satellite cell exhaustion. There was also a tendency for
association between satellite cell activity and good function of the flap. As we could not show
statistically significant figures correlating these factors, the role of satellite cell exhaustion in
connection to poor results after long follow-up time remains to be proved.
However, the former suggestion is confirmed by our other result as normal, regenerated
muscle structure seen in MRI correlated with good function of the muscle flap. In the same
study, there was a correlation between a longer follow-up time and weaker muscle function
and poorer muscle structure.
The choice of muscle for microneurovascular transfer is still a matter of debate, and at least
nine different muscles have been used during the search for the most appropriate one (Aviv et
Urken, 1992). In our study three different muscles, serratus, gracilis and latissimus dorsi, were
used.
Many authors prefer gracilis muscle as the first choice in microneurovascular muscle transfer
because it has parallel muscle fibers and a constant neurovascular supply with large enough
vessels to make microanastomosis safe. The muscle fibers show long amplitude of the
contraction even when reduced in length, which is more important than the force when
muscle is placed in the face. (Frey et Giovanoli, 2002) In a study based on cadaveric
dissections, the most suitable flap was latissimus dorsi, followed by the gracilis (Bove et al,
1998).
In our study, the most severe atrophy was associated with the use of the serratus anterior
muscle. It remains possible that the trend observed was due to muscle type or the fact that the
serratus muscle was used in the first patients in the series, where the functional outcome was
poorer than that of the later patients.
The correlation between age and regeneration of nerve and muscle is a subject of
investigation. In our series, the mean age of the patients at the time of surgery was 41 years.
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As most of them were middle-aged (only one was a child), we could not show the effect of
age on recovery of muscle function and final functional outcome. A recent study on patients
with a mean age of 22 years, however, reported a tendency for younger patients to achieve
earlier functional recovery (Terzis et Noah, 1997). Similar results were obtained in a study
with nerve-grafting or cranial substitution techniques, age being the most important factor
influencing the functional outcome. There was a significant poorer outcome in patients older
than 60 years (Guntinas-Lichius et al, 2006)
Experimental studies confirm that the youth of an animal given a graft is an important
determinant of the success of regeneration of skeletal muscle (Carlson et Faulkner, 1989). The
comparably older age of our patients must, therefore, be considered when evaluating our
results. In a study comparing a group of children under fifteen years of age and the adults
treated with two-stage microneurovascular muscle transfer, children had a significantly higher
rate of the best possible grade of the function than adults. Also the first muscle contraction
after surgery was detected significantly earlier in children than in adults (Ueda et al, 1998).
In our study, younger age of the patient correlated with a higher number of viable axons at the
distal end of the nerve graft at the time of muscle transfer. This result is consistent with the
fact that nerve regeneration is usually better in younger patients (Conley et May, 2003)
although in one human cross-over nerve graft study, numbers of regenerating axons did not
correlate with age (Jacobs et al, 1996). In our study, the expression of p75NGFR was
significantly higher in younger than in older patients. A high level of expression of p75NGFR
was weakly associated with a better function of transplanted muscle (p=0.087). Thus, age
might be one factor influencing the functional outcome of the surgical treatment and the entire
neural and muscular regeneration process.
Most of our patients 78% (21 out of 27) were satisfied with the result of their facial
reanimation. Other studies have reported similar figures for satisfaction among patients
(O´Brien et al, 1990; Kumar et Hassan, 2002). In the latter, 67% (10 out of 15) patients
considered the result of a two-stage procedure as excellent or very good (Kumar et Hassan,
2002). As facial paralysis can be a catastrophic event for a patient, it is therefore very easy to
believe that improvement of the mimic function will satisfy the patient. In our study, we could
show that the degree of satisfaction correlated well with a good final result.
2. Association between functional outcome and findings in MRI
To the knowledge of the author, our article (Ylä-Kotola et al, 2005) is the first study on MRI
appearance of free microneurovascular muscle flaps. In this study, we could show that a good
clinical function of the microneurovascular muscle flap correlated with normal structure in
MRI, implying that MRI can be used to detect even small free muscle flaps. MRI has been
used for imaging facial musculature before facial nerve grafting, and there was correlation
between abnormal muscle structure and poor functional outcome after nerve grafting (Kaylie
et al, 2003).
Moreover, five patients with pedicled latissimus dorsi cardiomyoplasty were MRI imaged 2-4
years after myoplasty. In the MRI images, the signal intensity was similar to that of
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subcutaneous fat, indicating strong fatty infiltration in muscle flap with intact vascular and
nerve supply. The authors suggest that the possible explanation for the poor structure of the
muscle is continuous electrical stimulation of the flap destructing muscle fibers. (Kalil-Filho
et al, 1994).
It is known that denervation of the muscle causes fatty infiltration and atrophy seen in MRI
and reinnervation can return the structure to normal (Uetani et al, 1993; Fleckenstein et al,
1993).
With microneurovascular muscles, reinnervation should occur, and in our study, six out of
fifteen muscle flaps showed normal muscle structure, confirming that reinnervation had taken
place. The other six of the muscle flaps had fatty appearance similar to that of denervated
muscles or of free microvascular muscle flaps (Fleckenstein et al, 1993; Salmi et al, 1995)
indicating that for some reason, reinnervation had not occurred regardless of nerve
anastomosis. Worse appearance of muscle structure in MRI correlated with the weaker
function of the muscle. This could indicate that failed reinnervation is at least one factor
resulting in a poor functional result. That led us to a new aspect of our study; to investigate by
histological methods the reinnervation of the microneurovascular muscle flaps.
3. Reinnervation of free microneurovascular muscle flaps
Two complex physiological features determine the final functional outcome after
microneurovascular muscle transfer, namely, the quality of nerve regeneration and
consequently, the functional recovery of the muscle transplant (Guelinckx  et Sinsel, 1996).
It is well known that muscle denervation, reinnervation, and transplantation alter the
expression of fast and slow muscle fibers (Oldfors et al, 1989; Frey et al, 1991; Jakubiec-
Puka, 1992; Frey et al, 1998). The typical signs of reinnervation-like type grouping of the
muscle can also be seen (Guelinckx et al, 1997;Giovanoli et al, 2000).
In previous studies, a significant type 1 specific atrophy and an increasing proportion of type
2 fibers in free non-innervated microvascular muscle flaps were found 9 months after surgery
(Kauhanen et al, 1998a; Kauhanen et al, 2004). In an experimental study with rabbits in two-
stage procedure for facial reanimation, type 2 fibers were also predominant (Rab et al, 2006).
In our study, in which the transplanted muscle was surgically neurotized with nerve
anastomosis, our findings were different and no clear shift was seen in fiber type distribution.
Nevertheless, adaptation of the graft to fast-twitch muscle activity favored better mimic
function. We hypothesize that in those cases in which fast fibers predominated at a later time
point, the choice of the donor nerve had been correct. Thus, the part of the facial nerve that
normally innervates fast mimic muscles should perhaps be selected to achieve fast movements
as spontaneous smile. Hence, our results are consistent with those of other studies indicating
the importance of the donor nerve type in microneurovascular muscle transfer (Frey et al,
1998; Nehrer-Tairych et al, 2000).
In general, long-lasting denervation leads to degeneration of skeletal muscle fibers and to a
decrease in the fiber diameter of denervated muscles (Schmalbruch et al, 1991; Sesodia et
Cullen, 1991; Zhang 1997; Carpenter et Karpati, 2001; Kalliainen et al, 2002). In
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experimental settings it has been demonstrated that reinnervation of a denervated muscle is
essential for regaining of the initial fiber size and muscle function (Schmalbruch et al, 1991;
Schmalbruch et Lewis, 1994; Cederna et al, 2001).
In our study with 18 muscle samples, the muscle fiber diameters of surgically reinnervated
muscle flaps showed a 40% decrease during a follow-up period of 1-10 years. In a study of a
few cases of facial reanimation, however, there was no significant decrease in fiber diameter
despite similar follow-up times (Yoshimura et al, 1998). Whether the difference between their
results and ours could be attributed to differences in functional recovery of the transplanted
muscles remains unknown, as no functional grading was reported in Yoshimura’s study
(Yoshimura et al, 1998). Moreover, the decrease in muscle fiber diameters noted in our series
was similar to that observed by Frey in seven patients (Frey et al, 1991).
Our present results show that 1-10 years after microneurovascular muscle transfer,
intramuscular expression of S-100 protein indicative to some extent of reinnervation was
present in all muscle biopsy samples studied. On the basis of indirect morphological features,
Yoshimura at al. hypothesized that reinnervation had failed to occur in a few of their cases of
human microneurovascular muscle transfer, and that the flap had therefore atrophied
(Yoshimura et al, 1998). In our study, however, despite obvious muscle innervation, muscle
morphology was not fully restored in all cases. Moreover, the density of neural structures
correlated with neither atrophy, function, nor any other particular parameters in our patient
series. In experimental setting, reinnervated microvascular flaps showed a considerable
amount of muscle atrophy regardless of good reinnervation. Thus, it seems that muscle fiber
size is affected by factors other than innervation alone (Kostakoglu et al, 1995; Goldspink et
al, 1995). In general, muscle fibers kept at less than resting length or inactive will eventually
atrophy (Wichester et Goneyea, 1992; Roy et al, 1992). In addition, in a previous study on the
application of free muscle flaps to the lower limb, in which the nerve was not re-connected,
expression of S-100 and PGP 9.5 had disappeared at 2 weeks. However, by 9 months after
surgery, it had spontaneously reappeared in two thirds of patients, indicating spontaneous
“intrinsic” neurotization of flaps as part of the regenerative regime (Kauhanen et al, 2003).
In our study, control biopsies taken during the muscle transfer showed no proliferative
activity in satellite cells. Satellite cell activation is known to occur after denervation (Oldfors
et al, 1989; Gosselin et al, 1994; Kuschel et al, 1999; Yoshimura et Harii, 1999) and muscle
transplantation (Carlson et Faulkner, 1988; Carlson et Faulkner, 1989). In our study, 60 % of
the muscle samples showed satellite cell activity indicating that regeneration takes place even
several years after microneurovascular muscle transfer even though reinnervation seems to be
completed. This finding is compatible with earlier observations on the continuation of muscle
regeneration years after muscle transfer (Yoshimura et al, 1998).  If there are no contractile
stimuli or innervation is incomplete, the repeated attempts at regeneration will eventually
exhaust satellite cells (Schmalbruch et Lewis, 1994; Yoshimura et al, 1998). Depletion of
satellite cells impairs contractile function and the ability to repair tissue is lost (Jejurikar et al,
2002). Opinions differ as to whether reinnervation promotes myogenic potential or whether
regenerating muscle fibers actually enhance neural ingrowth (Carlson et Faulkner, 1988). In
our study, even if the muscle flap was reinnervated there were signs of continuous muscle
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regeneration. This might indicate that reinnervation has occurred soon after transplantation
and later, when biopsies are taken at the time-point convenient to refinement surgery, there
might have been many contributing factors other than reinnervation alone. It can be
summarized that although the free microneurovascular muscle flaps seem to be reinnervated,
the morphology is not unaltered and there are still attempts at muscle regeneration going on.
The question arises if nerve regeneration through the nerve graft is good enough to maintain
the muscle structure.
4. Immunohistochemical findings in human nerve grafts
In our study with 37 nerve graft specimen, the average proportion of viable fibers at the distal
end of the nerve graft was about 40% of that in control samples and thin nerve fibers were
characterized by endoneurial fibrosis although showing individual variation. In earlier human
studies, the results were similar to ours in terms of fibrosis and diminished number of viable
nerve fibers grown to the distal end of the grafted nerve (Vedung et Olsson, 1982; Frey et al,
1991; Frey et al, 1996). The number of regenerated axons did not correlate with functional
outcome as also shown earlier (Frey et al, 1991; Frey et al, 1996).
The use of vascularized nerve grafts has been explained by better survival of neural tissue
(Koshima et Harii, 1985; Schultes et al, 2001). Our nerve grafts were nonvascularized sural
nerve grafts, but they showed good vascularization regardless of fibrosis.
In an experimental acellular nerve conduit model, it has been shown that neovascularization
preceded axonal regeneration. Newly formed axons and Schwann cells never exceeded the
area of vascularization (Hobson et al, 1997). Although vascularization contributes to nerve
regeneration, the regeneration process certainly involves many other factors as well (Hobson
et al, 1997; Sondell et al, 2000). In our material, the axon number is reduced even though
vascularity is good: it remains obscure whether neovascularization within the nerve graft
occurred too late to have a positive effect on nerve regeneration, as the timepoint when a
sample was taken was constant in our study. We therefore hypothesize that if there were less
vascularity, the nerve would be even more fibrous.
It has been suggested that VEGF is one of the factors contributing not only to vascularity but
also to nerve regeneration (Carmeliet et Storkebaum, 2002; Storkebaum et al, 2004). Two
similar experimental models showed that the effect of added VEGF in nerve regeneration was
dose-dependent (Sondell et al, 1999b; Hobson et al, 2000). Apparently only the vascular
structures and Schwann cells were stimulated with lower concentration of VEGF (Sondell et
al, 1999b). Higher concentration of VEGF stimulated also axonal regeneration (Hobson et al,
2000). In our material, we discovered good vascularity but moderate nerve regeneration. We
do not know the amount of VEGF expression in the graft immediately after nerve transfer. It
may have been too low to stimulate the growth of neural structures effectively but high
enough to grow the vascular structures. This hypothesis is supported by our finding that there
was no statistical correlation between the expression of VEGF and viable axons at the distal
end of the nerve graft.
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The expression of VEGF and Flt-1 receptor was distibuted quite similarly in our study, as the
percentage of moderate immunopositivity (grade 2) was 62% and 55%, respectively. The
other receptor, Flk-1, was expressing itself much weaker, only 14% had grade 2
immunopositivity. It has been proposed that the neurotrophic effect of VEGF is mostly
mediated through Flk-1 (Zhang et al, 2003). As we could not show causality between the
expression of VEGF and neurotrophism, one explanation could be the mild immunopositivity
of Flk-1 receptor in our data.
The expression of VEGF was not associated with the expression of p75NGFR at the distal
ends of the nerve graft. If growth factors and their receptors are needed at certain accurate
time points to function correctly in nerve regeneration, it is difficult to estimate statistical
significances in our human material, as clinical rules require us to take samples at a constant
time-point.
In our series, we could show p75NGF receptor expression in every nerve graft sample. In
most cases, the expression was strong, grade 3 percentage being 51%. In an experimental
setting, all the regenerating spinal axons expressed p75NGFR, while none of the motoneurons
that failed to regenerate expressed p75NGFR. Hence, the authors suggest that p75NGFR
could be a marker of ongoing axonal regeneration (Wu et al, 2004). Our results imply that
high expression of p75NGFR in nerve grafts at the time of muscle transfer is favourable for
the regeneration process, but further studies are needed in this field.
There was no correlation between p75NGFR and the number of viable axons in our data. This
could mean that p75NGFR is expressed during a limited time period of the nerve regeneration
process. In an experimental work, Liu et al. describe a decline in NGF and p75NGFR
expression at a wound when axonal sprouts had reached the distal segment (Liu et al, 1995).
In our study, p75NGFR expression was monitored at only one time point owing to obvious
limitations in human tissue sampling. P75NGFR also co-operates with other receptors and
neurotrophins in a complex way (Schor, 2005; Ferri et al, 2002) so that further research is
warranted to immunostain different receptors combined with neurotrophins.
Our study shows that VEGF, Flk-1, Flt-1 and p75NGFR are expressed in human nerve grafts
and that the pattern of expression is unlike that in control nerves. This might indicate that
regeneration is continuing in nerve grafts at the moment of muscle transfer as the growth
factors and the receptors are still present.
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5. Future prospects
In present study, we wanted to evaluate the results of the facial reanimation surgery as well as
nerve and muscle regeneration within the same human model. As discussed above, many
factors contribute to the results of the study due to the obvious limitations in human
experiments and tissue sampling. However, further research in this field is essential in order
to gain knowledge about nerve and muscle regeneration. I hope that in near future, with
increased knowledge of growth factors working together in regeneration process, patients
with severe illnesses demanding microneurovascular free muscle flaps will also benefit from
this kind of research. In facial reanimation model, both nerve and muscle regeneration and
brain plasticity are important factors influencing the outcome of the surgery. It is of extensive
importance that the actual in vivo situation in human tissue has been described when planning




1. Most of the patients achieved good functional result after two-stage reanimation, and
they were satisfied with the result. Mimic function, however, was poorer with longer
postoperative follow-up time.
2. The volume of the free microneurovascular muscle flaps declined significantly
comparing the initial volume of the flap. There was a correlation between good mimic
function and normal muscle structure seen in MRI.
3. Muscle fiber diameter was diminished by 40% compared to control values despite the
fact that all samples were reinnervated. Proliferative activity of satellite cells was seen
in 60% of the samples but it tended to decline with prolonged follow-up time. Severe
muscle atrophy correlated with prolonged intraoperative ischaemia suggesting that the
duration of ischaemia should be kept in minimum.
4. Although all the nerve grafts were well vascularized, there was fibrosis in nerve grafts
with fewer and thinner axons compared to control nerves.
5. P75NGFR was expressed in every nerve graft in axons whereas in control nerves, the
expression of p75NGFR was low or absent. The expression of p75NGFR was higher
in younger than older patients. VEGF and Flt-1 were strongly expressed in nerve
grafts, but in control nerves the immunopositivity was low. This indicates that these
growth factors and receptors are present in human nerve grafts during the regeneration
process.
6. Mimic function was better in patients with a preponderance of fast fibers in muscle
transplants. A high expression of p75NGFR was often seen in patients with better
mimic function (ns). The number of viable axons in the distal ends of the nerve grafts
did not correlate with the function of the transplanted microneurovascular muscle.
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